Loading...
Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer
It is still controversial whether cervical cancer patients with clinical responses after neoadjuvant chemotherapy (NACT) have a better long-term survival or not. This study was designed to investigate the effect of the clinical response on the disease-free survival (DFS) of cervical cancer patients...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5350004/ https://ncbi.nlm.nih.gov/pubmed/27557523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11460 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|